Skip to main content

Table 1 Response rates by country and proportions of the patients prescribed desferrioxamine from each country

From: An international survey of patients with thalassemia major and their views about sustaining life-long desferrioxamine use

Country

CY

EG

GR

HK

IN

IR

IT

JO

TA

US

Total

Membership

636

2,801

922

334

823

6,810

840

360

302

310

14,138

Questionnaires dispatched

300

300

200

300

300

300

300

300

300

300

2,900

Questionnaires completed

275

199

118

159

235

215

147

232

231

77

1,888

Response rate (%)

92

66

59

53

78

72

49

77

77

26

65

Desferrioxamine use, N (%)

267 (97)

120 (60)

112 (95)

147 (93)

128 (55)

200 (93)

132 (90)

185 (80)

212 (92)

70 (91)

1573 (83)

  1. Cyprus (CY), Egypt (EG), Greece (GR), Hong Kong (HK), India (IN), Iran (IR), Italy (IT), Jordan (JO), Taiwan (TA), United States (US)